Adherence to colchicine treatment and colchicine resistance in a multicentric FMF national cohort
- Autori: R. Gallizzi, M. Bustaffa, F. Mazza, D. Sutera, G. Fabio, L. Obici, M. Alessio, D. Rigante, L. Cantarini, A. Insalaco, M. Cattalini, M. C. Maggio, G. Simonini, A. N. Olivieri, S. Pastori, M. Lancieri, F. Calzantini, N. Ruperto, M. Gattorno
- Anno di pubblicazione: 2020
- Tipologia: Poster pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/464195
Abstract
Introduction: Colchicine is the standard treatment for Familiar Mediterranean Fever (FMF), however about 5% of patients (pts) experience colchicine resistance. There is no standard definition of colchicine resistance. Recently a panel of experts elaborated a new definition based on a Delphi consensus approach. Objectives: We aim to describe main features of the disease and clinical outcome of a cohort of FMF pts with particular interest on the colchicine resistance and tolerability according to the definitions proposed by the recent consensus.